Blalock A, Mason MF, Morgan HJ, Riven SS. Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed. Ann Surg 110:544, 1939.
Blexrud MD, Windebank AJ, Daube JR: Long term follow-up of 121 patients with benign fasciculations. Neurology 34:622, 1993.
Bril V, Kojic J, Dhanani A: The long-term clinical outcome of myasthenia gravis in patients with thymoma. Neurology 51:1198, 1998.
Brody IA: Muscle contracture induced by exercise: A syndrome attributable to decreased relaxing factor. N Engl J Med 281:187, 1969.
Brown P, Rothwell PJ, Marsden CD: The stiff leg syndrome. J Neurol Neurosurg Psychiatry 62:31, 1997.
Buckingham JM, Howard FM Jr, Bernatz PE, et al: The value of thymectomy in myasthenia gravis: A computer-assisted matched study. Ann Surg 184:453, 1976.
Burke G, Cossins J, Maxwell S, et al: Rapsyn mutation in hereditary myasthenia. Distinct early and late phenotypes. Neurology 61:826, 2003.
Burns RJ, Bretag AH, Blumbergs PC, Harbord MG: Benign familial disease with muscle mounding and rippling. J Neurol Neurosurg Psychiatry 57:344, 1994.
Buzzard EF: The clinical history and postmortem examination of 5 cases of myasthenia gravis. Brain 28:438, 1905.
Cannon SC: An expanding view for the molecular basis of familial periodic paralysis. Neuromuscul Disord 12:533, 2002.
Cannon SC, Brown RH Jr, Corey DP: Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels. Biophys J 65:270, 1993.
Celebisoy N, Cologlu Z, Akbaba Y, et al: Continuous muscle fibre activity: A case treated with acetazolamide. J Neurol Neurosurg Psychiatry 64:256, 1998.
Cöers C, Telerman-Toppet N, Durda J: Neurogenic benign fasciculations, pseudomyotonia, and pseudotetany. Arch Neurol 38:282, 1981.
Cogan DG: Myasthenia gravis: A review of the disease and a description of lid twitch as a characteristic sign. Arch Ophthalmol 74:217, 1965.
Compston DAS, Vincent A, Newsom-Davis A, Batchelor JR: Clinical, pathological, HLA antigen, and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103:579, 1980.
Conn JW, Knopf RF, Nesbit RM: Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107:159, 1964.
Conn JW, Rovner DR, Cohen EL: Licorice-induced pseudoaldosteronism: Hypertension, hypokalemia, aldosteronopenia and suppressed plasma renin activity. JAMA 205:492, 1968.
Cortes-Vicente E, Gallardo E, Martinez MA, et al: Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin. JAMA Neurol 73:1099, 2016.